A possible role of dystrophin in neuronal excitability: A review of the current literature

Neuroscience and Biobehavioral Reviews

Volumn 51, Issue , 2015, Pages 255-262

  Hendriksen, Ruben G F ^a   Hoogland, Govert ^a,b   Schipper, Sandra ^b   Hendriksen, Jos G M ^a,c   Vles, Johan S H ^a,c   Aalbers, Marlien W ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c EPILEPSY CENTER KEMPENHAEGHE   (Netherlands)

Author keywords

Duchenne muscular dystrophy; Dystrophin; Epilepsy; Seizures

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ALBUMIN; AQUAPORIN 4; CELL PROTEIN; DP71 PROTEIN; DYSTROBREVIN; DYSTROPHIN; EPSILON SARCOGLYCAN; MESSENGER RNA; SYNTROPHIN; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; ANIMAL CELL; ASTROCYTOSIS; ATTENTION; BASAL GANGLION; BECKER MUSCULAR DYSTROPHY; BLOOD BRAIN BARRIER; BRAIN STEM; CENTRAL NERVOUS SYSTEM FUNCTION; CEREBELLUM; COGNITIVE DEFECT; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; EPILEPSY; EPILEPTOGENESIS; EXCITATORY POSTSYNAPTIC POTENTIAL; EXON SKIPPING; GENE MUTATION; GENETIC SUSCEPTIBILITY; GLIA CELL; HIPPOCAMPUS; HYPOTHALAMUS; IMMUNOREACTIVITY; LANGUAGE PROCESSING; LEARNING DISORDER; MESIAL TEMPORAL LOBE EPILEPSY; MOUSE; NERVE CELL EXCITABILITY; NERVE DEGENERATION; NONHUMAN; POSTSYNAPTIC DENSITY; PREFRONTAL CORTEX; PREVALENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; READING; REVIEW; SEIZURE; SPINAL CORD; SYMPTOMATOLOGY; THALAMUS; X CHROMOSOME; ANIMAL; BRAIN; GENETICS; HUMAN; METABOLISM; MUSCLE; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BRAIN; DYSTROPHIN; EPILEPSY; HUMANS; MUSCLES; MUSCULAR DYSTROPHY, DUCHENNE; NEURONS;

EID: 84923061869     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2015.01.023     Document Type: Review

References (112)

1. Ahn A.H., Kunkel L.M. The structural and functional diversity of dystrophin. Nat. Genet. 1993, 3:283-291.
2. al-Qudah A.A., Kobayashi J., Chuang S., Dennis M., Ray P. Etiology of intellectual impairment in Duchenne muscular dystrophy. Pediatr. Neurol. 1990, 6:57-59.
3. Albrecht D.E., Froehner S.C. Syntrophins and dystrobrevins: defining the dystrophin scaffold at synapses. Neurosignals 2002, 11:123-129.
4. Albuquerque E.X., Pereira E.F., Alkondon M., Rogers S.W. Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol. Rev. 2009, 89:73-120.
5. Alvestad S., Hammer J., Hoddevik E.H., Skare O., Sonnewald U., Amiry-Moghaddam M., Ottersen O.P. Mislocalization of AQP4 precedes chronic seizures in the kainate model of temporal lobe epilepsy. Epilepsy Res. 2013, 105:30-41.
6. Anderson J.L., Head S.I., Morley J.W. Long-term depression is reduced in cerebellar Purkinje cells of dystrophin-deficient mdx mice. Brain Res. 2004, 1019:289-292.
7. Anderson J.L., Head S.I., Morley J.W. Duchenne muscular dystrophy and brain function. Muscular Dystrophy 2012, 91-122. Intech. M. Hedge, A. Ankala (Eds.).
8. Anderson J.L., Head S.I., Rae C., Morley J.W. Brain function in Duchenne muscular dystrophy. Brain: J. Neurol. 2002, 125:4-13.
9. Austin R.C., Morris G.E., Howard P.L., Klamut H.J., Ray P.N. Expression and synthesis of alternatively spliced variants of Dp71 in adult human brain. Neuromuscul. Disord. 2000, 10:187-193.
10. Bar S., Barnea E., Levy Z., Neuman S., Yaffe D., Nudel U. A novel product of the Duchenne muscular dystrophy gene which greatly differs from the known isoforms in its structure and tissue distribution. Biochem. J. 1990, 272:557-560.
11. Barbujani G., Russo A., Danieli G.A., Spiegler A.W., Borkowska J., Petrusewicz I.H. Segregation analysis of 1885 DMD families: significant departure from the expected proportion of sporadic cases. Hum. Genet. 1990, 84:522-526.
12. Binder D.K., Nagelhus E.A., Ottersen O.P. Aquaporin-4 and epilepsy. Glia 2012, 60:1203-1214.
13. Blake D.J., Kröger S. The neurobiology of Duchenne muscular dystrophy: learning lessons from muscle?. Trends Neurosci. 2000, 23:92-99.
14. Blake D.J., Weir A., Newey S.E., Davies K.E. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol. Rev. 2002, 82:291-329.
15. Boyce F.M., Beggs A.H., Feener C., Kunkel L.M. Dystrophin is transcribed in brain from a distant upstream promoter. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:1276-1280.
16. Bresolin N., Castelli E., Comi G.P., Felisari G., Bardoni A., Perani D., Grassi F., Turconi A., Mazzucchelli F., Gallotti D., et al. Cognitive impairment in Duchenne muscular dystrophy. Neuromuscul. Disord 1994, 4:359-369.
17. Brünig I., Suter A., Knuesel I., Lüscher B., Fritschy J.M. GABAergic terminals are required for postsynaptic clustering of dystrophin but not of GABA(A) receptors and gephyrin. J. Neurosci: Off. J. Soc. Neurosci. 2002, 22:4805-4813.
18. Buono R.J., Lohoff F.W., Sander T., Sperling M.R., O'Connor M.J., Dlugos D.J., Ryan S.G., Golden G.T., Zhao H., Scattergood T.M., Berrettini W.H., Ferraro T.N. Association between variation in the human KCNJ10 potassium ion channel gene and seizure susceptibility. Epilepsy Res. 2004, 58:175-183.
19. Carretta D., Santarelli M., Vanni D., Carrai R., Sbriccoli A., Pinto F., Minciacchi D. The organisation of spinal projecting brainstem neurons in an animal model of muscular dystrophy. A retrograde tracing study on mdx mutant mice. Brain Res. 2001, 895:213-222.
20. Chamberlain J.S., Pearlman J.A., Muzny D.M., Gibbs R.A., Ranier J.E., Caskey C.T., Reeves A.A. Expression of the murine Duchenne muscular dystrophy gene in muscle and brain. Science 1988, 239:1416-1418.
21. Chavas J., Forero M.E., Collin T., Llano I., Marty A. Osmotic tension as a possible link between GABA(A) receptor activation and intracellular calcium elevation. Neuron 2004, 44:701-713.
22. Cheung H.H., Takagi N., Teves L., Logan R., Wallace M.C., Gurd J.W. Altered association of protein tyrosine kinases with postsynaptic densities after transient cerebral ischemia in the rat brain. J. Cereb. Blood Flow Metab.: Off. J. Int. Soc. Cereb. Blood Flow Metab. 2000, 20:505-512.
23. Coccurello R., Castellano C., Paggi P., Mele A., Oliverio A. Genetically dystrophic mdx/mdx mice exhibit decreased response to nicotine in passive avoidance. NeuroReport 2002, 13:1219-1222.
24. Connors N.C., Adams M.E., Froehner S.C., Kofuji P. The potassium channel Kir4.1 associates with the dystrophin-glycoprotein complex via alpha-syntrophin in glia. J. Biol. Chem. 2004, 279:28387-28392.
25. Corda M.G., Orlandi M., Lecca D., Carboni G., Frau V., Giorgi O. Pentylenetetrazol-induced kindling in rats: effect of GABA function inhibitors. Pharmacol. Biochem. Behav. 1991, 40:329-333.
26. Cotton S., Voudouris N.J., Greenwood K.M. Intelligence and Duchenne muscular dystrophy: full-scale, verbal, and performance intelligence quotients. Dev. Med. Child Neurol. 2001, 43:497-501.
27. Cowan L.D. The epidemiology of the epilepsies in children. Mental Retard. Dev. Disabil. Res. Rev. 2002, 8:171-181.
28. Cowan L.D., Bodensteiner J.B., Leviton A., Doherty L. Prevalence of the epilepsies in children and adolescents. Epilepsia 1989, 30:94-106.
29. Craig A.M., Kang Y. Neurexin-neuroligin signaling in synapse development. Curr. Opin. Neurobiol. 2007, 17:43-52.
30. Culligan K., Glover L., Dowling P., Ohlendieck K. Brain dystrophin-glycoprotein complex: persistent expression of beta-dystroglycan, impaired oligomerization of Dp71 and up-regulation of utrophins in animal models of muscular dystrophy. BMC Cell Biol. 2001, 2:2.
31. Cyrulnik S.E., Hinton V.J. Duchenne muscular dystrophy: a cerebellar disorder?. Neurosci. Biobehav. Rev. 2008, 32:486-496.
32. Daoud F., Candelario-Martinez A., Billard J.M., Avital A., Khelfaoui M., Rozenvald Y., Guegan M., Mornet D., Jaillard D., Nudel U., Chelly J., Martinez-Rojas D., Laroche S., Yaffe D., Vaillend C. Role of mental retardation-associated dystrophin-gene product Dp71 in excitatory synapse organization, synaptic plasticity and behavioral functions. PLoS ONE 2009, 4:e6574.
33. Das A., Wallace G.C.t., Holmes C., McDowell M.L., Smith J.A., Marshall J.D., Bonilha L., Edwards J.C., Glazier S.S., Ray S.K., Banik N.L. Hippocampal tissue of patients with refractory temporal lobe epilepsy is associated with astrocyte activation, inflammation, and altered expression of channels and receptors. Neuroscience 2012, 220:237-246.
34. de Brouwer A.P., Nabuurs S.B., Verhaart I.E., Oudakker A.R., Hordijk R., Yntema H.G., Hordijk-Hos J.M., Voesenek K., de Vries B.B., van Essen T., Chen W., Hu H., Chelly J., den Dunnen J.T., Kalscheuer V.M., Aartsma-Rus A.M., Hamel B.C., van Bokhoven H., Kleefstra T. A 3-base pair deletion, c.9711_9713del, in DMD results in intellectual disability without muscular dystrophy. Eur. J. Hum. Genet. 2014, 22:480-485.
35. De Sarro G., Ibbadu G.F., Marra R., Rotiroti D., Loiacono A., Donato Di Paola E., Russo E. Seizure susceptibility to various convulsant stimuli in dystrophin-deficient mdx mice. Neurosci. Res. 2004, 50:37-44.
36. Desmond N.L., Levy W.B. Changes in the postsynaptic density with long-term potentiation in the dentate gyrus. J. Comp. Neurol. 1986, 253:476-482.
37. Duchenne G.B.A. Reserches sur la paralysie musculaire pseudeohypertrofique, ou paralysie myo-sclerosique. Arch. Gen. Med. 1868, 11. 5-25, 179-209, 305-121, 421-143, 552-188.
38. Durbeej M., Campbell K.P. Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. Curr. Opin. Genet. Dev. 2002, 12:349-361.
39. Ehmsen J., Poon E., Davies K. The dystrophin-associated protein complex. J. Cell Sci. 2002, 115:2801-2803.
40. Ehrlich I., Malinow R. Postsynaptic density 95 controls AMPA receptor incorporation during long-term potentiation and experience-driven synaptic plasticity. J. Neurosci.: Off. J. Soc. Neurosci. 2004, 24:916-927.
41. Eid T., Lee T.S., Thomas M.J., Amiry-Moghaddam M., Bjornsen L.P., Spencer D.D., Agre P., Ottersen O.P., de Lanerolle N.C. Loss of perivascular aquaporin 4 may underlie deficient water and K+ homeostasis in the human epileptogenic hippocampus. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:1193-1198.
42. Emery A.E. The muscular dystrophies. Lancet 2002, 359:687-695.
43. Ervasti J.M., Campbell K.P. Membrane organization of the dystrophin-glycoprotein complex. Cell 1991, 66:1121-1131.
44. Etemadifar M., Molaei S. Epilepsy in boys with Duchenne muscular dystrophy. J. Res. Med. Sci. 2004, 3:116-119.
45. Ferraro T.N., Golden G.T., Smith G.G., Martin J.F., Lohoff F.W., Gieringer T.A., Zamboni D., Schwebel C.L., Press D.M., Kratzer S.O., Zhao H., Berrettini W.H., Buono R.J. Fine mapping of a seizure susceptibility locus on mouse chromosome 1: nomination of Kcnj10 as a causative gene. Mamm. Genome 2004, 15:239-251.
46. Frigeri A., Nicchia G.P., Nico B., Quondamatteo F., Herken R., Roncali L., Svelto M. Aquaporin-4 deficiency in skeletal muscle and brain of dystrophic mdx mice. FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol. 2001, 15:90-98.
47. Ghedini P.C., Avellar M.C., De Lima T.C., Lima-Landman M.T., Lapa A.J., Souccar C. Quantitative changes of nicotinic receptors in the hippocampus of dystrophin-deficient mice. Brain Res. 2012, 1483:96-104.
48. Goodwin F., Muntoni F., Dubowitz V. Epilepsy in Duchenne and Becker muscular dystrophies. Eur. J. Paediatr. Neurol.: Off. J. Eur. Paediatr. Neurol. Soc. 1997, 1:115-119.
49. Gorecki D.C., Barnard E.A. Specific expression of G-dystrophin (Dp71) in the brain. NeuroReport 1995, 6:893-896.
50. Gorecki D.C., Lukasiuk K., Szklarczyk A., Kaczmarek L. Kainate-evoked changes in dystrophin messenger RNA levels in the rat hippocampus. Neuroscience 1998, 84:467-477.
51. Gotman J., Levtova V. Amygdala-hippocampus relationships in temporal lobe seizures: a phase-coherence study. Epilepsy Res. 1996, 25:51-57.
52. Goulden K.J., Shinnar S., Koller H., Katz M., Richardson S.A. Epilepsy in children with mental retardation: a cohort study. Epilepsia 1991, 32:690-697.
53. Graciotti L., Minelli A., Minciacchi D., Procopio A., Fulgenzi G. GABAergic miniature spontaneous activity is increased in the CA1 hippocampal region of dystrophic mdx mice. Neuromuscul. Disord. 2008, 18:220-226.
54. Haj-Yasein N.N., Jensen V., Vindedal G.F., Gundersen G.A., Klungland A., Ottersen O.P., Hvalby O., Nagelhus E.A. Evidence that compromised K+ spatial buffering contributes to the epileptogenic effect of mutations in the human Kir4.1 gene (KCNJ10). Glia 2011, 59:1635-1642.
55. Heinemann U., Kaufer D., Friedman A. Blood-brain barrier dysfunction, TGFbeta signaling, and astrocyte dysfunction in epilepsy. Glia 2012, 60:1251-1257.
56. Hendriksen J.G., Vles J.S. Are males with Duchenne muscular dystrophy at risk for reading disabilities?. Pediatr. Neurol. 2006, 34:296-300.
57. Hendriksen J.G., Vles J.S. Neuropsychiatric disorders in males with Duchenne muscular dystrophy: frequency rate of attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder, and obsessive-compulsive disorder. J. Child Neurol. 2008, 23:477-481.
58. Heuser K., Eid T., Lauritzen F., Thoren A.E., Vindedal G.F., Tauboll E., Gjerstad L., Spencer D.D., Ottersen O.P., Nagelhus E.A., de Lanerolle N.C. Loss of perivascular Kir4.1 potassium channels in the sclerotic hippocampus of patients with mesial temporal lobe epilepsy. J. Neuropathol. Exp. Neurol. 2012, 71:814-825.
59. Hinterkeuser S., Schroder W., Hager G., Seifert G., Blumcke I., Elger C.E., Schramm J., Steinhauser C. Astrocytes in the hippocampus of patients with temporal lobe epilepsy display changes in potassium conductances. Eur. J. Neurosci. 2000, 12:2087-2096.
60. Jagadha V., Becker L.E. Brain morphology in Duchenne muscular dystrophy: a golgi study. Pediatr. Neurol. 1988, 4:87-92.
61. Kim J.E., Yeo S.I., Ryu H.J., Kim M.J., Kim D.S., Jo S.M., Kang T.C. Astroglial loss and edema formation in the rat piriform cortex and hippocampus following pilocarpine-induced status epilepticus. J. Comparat. Neurol. 2010, 518:4612-4628.
62. Kim T.W., Wu K., Black I.B. Deficiency of brain synaptic dystrophin in human Duchenne muscular dystrophy. Ann. Neurol. 1995, 38:446-449.
63. Knuesel I., Mastrocola M., Zuellig R.A., Bornhauser B., Schaub M.C., Fritschy J.M. Short communication: altered synaptic clustering of GABAA receptors in mice lacking dystrophin (mdx mice). Eur. J. Neurosci. 1999, 11:4457-4462.
64. Knuesel I., Zuellig R.A., Schaub M.C., Fritschy J.M. Alterations in dystrophin and utrophin expression parallel the reorganization of GABAergic synapses in a mouse model of temporal lobe epilepsy. Eur. J. Neurosci. 2001, 13:1113-1124.
65. Koenig M., Hoffman E.P., Bertelson C.J., Monaco A.P., Feener C., Kunkel L.M. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 1987, 50:509-517.
66. Kueh S.L., Dempster J., Head S.I., Morley J.W. Reduced postsynaptic GABAA receptor number and enhanced gaboxadol induced change in holding currents in Purkinje cells of the dystrophin-deficient mdx mouse. Neurobiol. Dis. 2011, 43:558-564.
67. Kueh S.L., Head S.I., Morley J.W. GABA(A) receptor expression and inhibitory post-synaptic currents in cerebellar Purkinje cells in dystrophin-deficient mdx mice. Clin. Exp. Pharmacol. Physiol. 2008, 35:207-210.
68. Lee J.S., Pfund Z., Juhasz C., Behen M.E., Muzik O., Chugani D.C., Nigro M.A., Chugani H.T. Altered regional brain glucose metabolism in Duchenne muscular dystrophy: a pet study. Muscle Nerve 2002, 26:506-512.
69. Lee T.S., Eid T., Mane S., Kim J.H., Spencer D.D., Ottersen O.P., de Lanerolle N.C. Aquaporin-4 is increased in the sclerotic hippocampus in human temporal lobe epilepsy. Acta Neuropathol. (Berl.) 2004, 108:493-502.
70. Lenzen K.P., Heils A., Lorenz S., Hempelmann A., Hofels S., Lohoff F.W., Schmitz B., Sander T. Supportive evidence for an allelic association of the human KCNJ10 potassium channel gene with idiopathic generalized epilepsy. Epilepsy Res. 2005, 63:113-118.
71. Lidov H.G. Dystrophin in the nervous system. Brain Pathol. 1996, 6:63-77.
72. Lidov H.G., Byers T.J., Kunkel L.M. The distribution of dystrophin in the murine central nervous system: an immunocytochemical study. Neuroscience 1993, 54:167-187.
73. Lidov H.G., Selig S., Kunkel L.M. Dp140: a novel 140kDa CNS transcript from the dystrophin locus. Hum. Mol. Genet. 1995, 4:329-335.
74. Lin Y., Jover-Mengual T., Wong J., Bennett M.V., Zukin R.S. PSD-95 and PKC converge in regulating NMDA receptor trafficking and gating. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:19902-19907.
75. Martone M.E., Hu B.R., Ellisman M.H. Alterations of hippocampal postsynaptic densities following transient ischemia. Hippocampus 2000, 10:610-616.
76. Medici V., Frassoni C., Tassi L., Spreafico R., Garbelli R. Aquaporin 4 expression in control and epileptic human cerebral cortex. Brain Res. 2011, 1367:330-339.
77. Melacini P., Vianello A., Villanova C., Fanin M., Miorin M., Angelini C., Dalla Volta S. Cardiac and respiratory involvement in advanced stage Duchenne muscular dystrophy. Neuromuscul. Disord. 1996, 6:367-376.
78. Miranda R., Sebrie C., Degrouard J., Gillet B., Jaillard D., Laroche S., Vaillend C. Reorganization of inhibitory synapses and increased PSD length of perforated excitatory synapses in hippocampal area CA1 of dystrophin-deficient mdx mice. Cereb. Cortex 2009, 19:876-888.
79. Mitchell L.A., Jackson G.D., Kalnins R.M., Saling M.M., Fitt G.J., Ashpole R.D., Berkovic S.F. Anterior temporal abnormality in temporal lobe epilepsy: a quantitative MRI and histopathologic study. Neurology 1999, 52:327-336.
80. Nagao Y., Harada Y., Mukai T., Shimizu S., Okuda A., Fujimoto M., Ono A., Sakagami Y., Ohno Y. Expressional analysis of the astrocytic Kir4.1 channel in a pilocarpine-induced temporal lobe epilepsy model. Front. Cell Neurosci. 2013, 7:104.
81. Nagelhus E.A., Horio Y., Inanobe A., Fujita A., Haug F.M., Nielsen S., Kurachi Y., Ottersen O.P. Immunogold evidence suggests that coupling of K+ siphoning and water transport in rat retinal Muller cells is mediated by a coenrichment of Kir4.1 and AQP4 in specific membrane domains. Glia 1999, 26:47-54.
82. Nakao K., Kito S., Muro T., Tomonaga M., Mozai T. Nervous system involvement in progressive muscular dystrophy. Proc. Aust. Assoc. Neurol. 1968, 5:557-564.
83. Nicchia G.P., Nico B., Camassa L.M., Mola M.G., Loh N., Dermietzel R., Spray D.C., Svelto M., Frigeri A. The role of aquaporin-4 in the blood-brain barrier development and integrity: studies in animal and cell culture models. Neuroscience 2004, 129:935-945.
84. Nico B., Frigeri A., Nicchia G.P., Corsi P., Ribatti D., Quondamatteo F., Herken R., Girolamo F., Marzullo A., Svelto M., Roncali L. Severe alterations of endothelial and glial cells in the blood-brain barrier of dystrophic mdx mice. Glia 2003, 42:235-251.
85. Nico B., Paola Nicchia G., Frigeri A., Corsi P., Mangieri D., Ribatti D., Svelto M., Roncali L. Altered blood-brain barrier development in dystrophic MDX mice. Neuroscience 2004, 125:921-935.
86. Nusser Z., Cull-Candy S., Farrant M. Differences in synaptic GABA(A) receptor number underlie variation in GABA mini amplitude. Neuron 1997, 19:697-709.
87. Pane M., Messina S., Bruno C., D'Amico A., Villanova M., Brancalion B., Sivo S., Bianco F., Striano P., Battaglia D., Lettori D., Vita G.L., Bertini E., Gualandi F., Ricotti V., Ferlini A., Mercuri E. Duchenne muscular dystrophy and epilepsy. Neuromuscul. Disord. 2013, 23:313-315.
88. Parames S.F., Coletta-Yudice E.D., Nogueira F.M., Nering de Sousa M.B., Hayashi M.A., Lima-Landman M.T., Lapa A.J., Souccar C. Altered acetylcholine release in the hippocampus of dystrophin-deficient mice. Neuroscience 2014, 269:173-183.
89. Perronnet C., Vaillend C. Dystrophins, utrophins, and associated scaffolding complexes: role in mammalian brain and implications for therapeutic strategies. J. Biomed. Biotechnol. 2010, 2010:849426.
90. Racine R.J., Gartner J.G., Burnham W.M. Epileptiform activity and neural plasticity in limbic structures. Brain Res. 1972, 47:262-268.
91. Rae C., Griffin J.L., Blair D.H., Bothwell J.H., Bubb W.A., Maitland A., Head S. Abnormalities in brain biochemistry associated with lack of dystrophin: studies of the mdx mouse. Neuromuscul. Disord. 2002, 12:121-129.
92. Roberts R.G., Coffey A.J., Bobrow M., Bentley D.R. Exon structure of the human dystrophin gene. Genomics 1993, 16:536-538.
93. Saadoun S., Tait M.J., Reza A., Davies D.C., Bell B.A., Verkman A.S., Papadopoulos M.C. AQP4 gene deletion in mice does not alter blood-brain barrier integrity or brain morphology. Neuroscience 2009, 161:764-772.
94. Sbriccoli A., Santarelli M., Carretta D., Pinto F., Granato A., Minciacchi D. Architectural changes of the cortico-spinal system in the dystrophin defective mdx mouse. Neurosci. Lett. 1995, 200:53-56.
95. Sekiguchi M., Zushida K., Yoshida M., Maekawa M., Kamichi S., Yoshida M., Sahara Y., Yuasa S., Takeda S., Wada K. A deficit of brain dystrophin impairs specific amygdala GABAergic transmission and enhances defensive behaviour in mice. Brain: J. Neurol. 2009, 132:124-135.
96. Sheen S.H., Kim J.E., Ryu H.J., Yang Y., Choi K.C., Kang T.C. Decrease in dystrophin expression prior to disruption of brain-blood barrier within the rat piriform cortex following status epilepticus. Brain Res. 2011, 1369:173-183.
97. Snow W.M., Anderson J.E., Fry M. Regional and genotypic differences in intrinsic electrophysiological properties of cerebellar Purkinje neurons from wild-type and dystrophin-deficient mdx mice. Neurobiol. Learn. Mem. 2014, 107:19-31.
98. Snow W.M., Anderson J.E., Jakobson L.S. Neuropsychological and neurobehavioral functioning in Duchenne muscular dystrophy: a review. Neurosci. Biobehav. Rev. 2013, 37:743-752.
99. Sogos V., Ennas M.G., Mussini I., Gremo F. Effect of dystrophin antisense oligonucleotides on cultured human neurons. Neurochem. Int. 1997, 31:447-457.
100. Sussman M. Duchenne muscular dystrophy. J. Am. Acad. Orthop. Surg. 2002, 10:138-151.
101. Taylor P.J., Betts G.A., Maroulis S., Gilissen C., Pedersen R.L., Mowat D.R., Johnston H.M., Buckley M.F. Dystrophin gene mutation location and the risk of cognitive impairment in Duchenne muscular dystrophy. PLoS ONE 2010, 5:e8803.
102. Tinsley J.M., Blake D.J., Zuellig R.A., Davies K.E. Increasing complexity of the dystrophin-associated protein complex. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:8307-8313.
103. Tozawa T., Itoh K., Yaoi T., Tando S., Umekage M., Dai H., Hosoi H., Fushiki S. The shortest isoform of dystrophin (Dp40) interacts with a group of presynaptic proteins to form a presumptive novel complex in the mouse brain. Mol. Neurobiol. 2012, 45:287-297.
104. Vaillend C., Billard J.M. Facilitated CA1 hippocampal synaptic plasticity in dystrophin-deficient mice: role for GABAA receptors?. Hippocampus 2002, 12:713-717.
105. Vaillend C., Billard J.M., Laroche S. Impaired long-term spatial and recognition memory and enhanced CA1 hippocampal LTP in the dystrophin-deficient Dmd(mdx) mouse. Neurobiol. Dis. 2004, 17:10-20.
106. Vaillend C., Perronnet C., Ros C., Gruszczynski C., Goyenvalle A., Laroche S., Danos O., Garcia L., Peltekian E. Rescue of a dystrophin-like protein by exon skipping in vivo restores GABAA-receptor clustering in the hippocampus of the mdx mouse. Mol. Ther.: J. Am. Soc. Gene Ther. 2010, 18:1683-1688.
107. Vaillend C., Ungerer A., Billard J.M. Facilitated NMDA receptor-mediated synaptic plasticity in the hippocampal CA1 area of dystrophin-deficient mice. Synapse 1999, 33:59-70.
108. van Vliet E.A., da Costa Araujo S., Redeker S., van Schaik R., Aronica E., Gorter J.A. Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain: J. Neurol. 2007, 130:521-534.
109. Waite A., Brown S.C., Blake D.J. The dystrophin-glycoprotein complex in brain development and disease. Trends Neurosci. 2012, 35:487-496.
110. Waite A., Tinsley C.L., Locke M., Blake D.J. The neurobiology of the dystrophin-associated glycoprotein complex. Ann. Med. 2009, 41:344-359.
111. Wallis T., Bubb W.A., McQuillan J.A., Balcar V.J., Rae C. For want of a nail. Ramifications of a single gene deletion, dystrophin, in the brain of the mouse. Front. Biosci. 2004, 9:74-84.
112. Yoshihara Y., Onodera H., Iinuma K., Itoyama Y. Abnormal kainic acid receptor density and reduced seizure susceptibility in dystrophin-deficient mdx mice. Neuroscience 2003, 117:391-395.